<DOC>
	<DOCNO>NCT01520779</DOCNO>
	<brief_summary>analysis risk factor intra-hepatic distant recurrence ( IDR ) hepatocellular carcinoma within 1 year radiofrequency ablation .</brief_summary>
	<brief_title>Recurrence Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>1 . Proved diagnosis HCC accord AASLD practice guideline ( Bruix Sherman , 2005 ) . 2 . Patients underwent RFA HCC BCLC ( The BarcelonaClinic LiverCancer stag system ) stage A ( Bruix Sherman , 2005 ) eligibility ability transplantation resection . 3 . Patients followedup 12 month exclude early recurrence i.e . recurrence within 1 year . 4 . Patients INR &lt; 1.5 prothrombin concentration &gt; 50 % . 5 . Platelet count &gt; 50000 cell/mm3 . 1 . Presence extrahepatic metastasis gross vascular invasion . 2 . Child class C patient . 3 . Follow period le 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Hepatocellular cacinoma</keyword>
	<keyword>Radiofrequancy ablation</keyword>
	<keyword>Intrahepatic recurrence</keyword>
</DOC>